C

    cbdMD Inc (YCBD)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • AMEX

    $0.49
    -0.01 (-1.68%)

    Market Cap: $5.60M

    Last updated: Aug 31, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    30%(9/30)
    Avg Surprise
    -178.34%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.20
    Range$-0.20 - $-0.20
    1 analysts
    Revenue Consensus
    $6M
    Range$6M - $6M
    1 analysts
    Dec 31, 2026
    EPS Consensus$-0.10
    Range$-0.10 - $-0.10
    1 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$0.00+100.0%
    60d ago$0.00+100.0%
    30d ago$0.00+100.0%
    7d ago$0.00+100.0%
    Current$-0.10
    Revenue Consensus
    $6M
    Range$6M - $6M
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.10---
    Sep 26EST
    		-$-0.20---
    Jun 26
    		$-0.11$-0.03-266.67%Miss+47.6%
    Mar 26
    		$-0.08$-0.05-60.00%Miss+95.8%
    Dec 25
    		$-0.04$-0.06+33.33%Beat+97.7%
    Sep 25
    		$-0.08$-0.07-14.29%Miss+72.7%
    Jun 25
    		$-0.21$-0.16-31.25%Miss+82.5%
    Mar 25
    		$-1.90$-1.60-18.75%Miss+82.4%
    Dec 24
    		$-1.76$-2.96+40.54%Beat+66.2%
    Sep 24
    		$-0.29$-0.45+34.82%Beat+75.8%
    Jun 24
    		$-1.20N/A+75.81%Beat+87.1%
    Mar 24
    		$-10.80$-6.00-80.00%Miss-35900.0%
    Dec 23
    		$-5.21$-5.92+11.99%Beat+81.9%
    Sep 23
    		$-1.21$-0.76-59.21%Miss-369.5%
    Jun 23
    		$-9.28N/A+67.78%Beat+95.3%
    Mar 23
    		$-0.03$-0.04+25.00%Beat+99.9%
    Dec 22
    		$-28.80N/A+77.14%Beat+77.1%
    Sep 22
    		$-0.26$-0.03-759.00%Miss-268.1%
    Jun 22
    		$-198.00$-18.00-1000.00%Miss-370.1%
    Mar 22
    		$-36.00$-14.40-150.00%Miss-27.2%
    Dec 21
    		$-126.00$-14.40-775.00%Miss-1086.4%
    Sep 21
    		$-0.07$-0.04-75.00%Miss+50.0%
    Jun 21
    		$-42.12$-21.60-95.00%Miss-319.5%
    Mar 21
    		$-28.30$-14.40-96.53%Miss+49.3%
    Dec 20
    		$-10.62$-3.60-195.00%Miss+79.2%
    Sep 20
    		$-0.14$-0.01-1300.00%Miss-117.7%
    Jun 20
    		$-10.04$-9.00-11.56%Miss+97.7%
    Mar 20
    		$-55.87$-25.20-121.71%Miss-79.6%
    Dec 19
    		$-51.05$-46.62-9.50%Miss-84983.3%
    Sep 19
    		$0.79$-0.17+564.71%Beat+890.0%
    Jun 19
    		$-428.40$-36.00-1090.00%Miss-1428100.0%
    Mar 19
    		$-31.10$-18.00-72.78%Miss-18394.1%
    Dec 18
    		$-0.06N/AN/ABeat+64.7%
    Sep 18
    		$-0.10N/AN/ABeat-233.3%
    Jun 18
    		$0.03N/AN/ABeat+123.1%
    Mar 18
    		$0.17N/AN/ABeat-
    Dec 17
    		$-0.17N/AN/ABeat-
    Sep 17
    		$-0.03$0.00N/AMiss-
    Mar 17
    		$-0.13$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-1.59EV/EBITDA63.94x
    Price/FCF-0.03xFCF Yield-3200.66%
    Profitability
    Profit Margin-13.80%Operating Margin-20.40%
    ROE-40.30%ROIC-35.28%
    Financial Health
    Debt/Equity0.00xInterest Coverage243.12x
    Current Ratio2.50xQuick Ratio1.37x
    Trading Statistics
    Beta2.17Avg Volume163.61K
    52-Week High$2.5652-Week Low$0.47

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.50
    SMA 20$0.53
    SMA 50$0.59
    SMA 200$0.79
    EMA 10$0.51
    EMA 20$0.52
    EMA 50$0.58
    EMA 200$0.81

    MACD

    Line: -0.03Signal: -0.03Hist: 0.00

    ADX

    ADX: 22.1+DI: 15.1-DI: 23.0

    Aroon & PSAR

    Aroon Up48.0
    Aroon Down12.0
    PSAR$0.57

    Bollinger Bands

    Upper Band$0.61
    Lower Band$0.44
    %B Position3153%(Upper)
    Band Width0.28

    RSI (14-Day)

    Neutral
    40.7

    Momentum Oscillators

    Stoch %K18.0
    Stoch %D23.6
    Williams %R-85.0
    ROC (10d)3.5%
    Momentum0.02
    CCI (20d)-56.8
    MFI (14d)42.9

    Volatility Measures

    ATR (14d)$0.04(8.2%)
    StdDev (20d)0.04
    Hist Vol69.8%(High)

    Volume Flow

    VWAP$0.50
    OBV645.5M
    AD Line2.7B
    CMF (20d)-0.210

    Volume Metrics

    Avg Vol (20d)152.7K
    Vol Ratio0.5x
    VWMA (20d)$0.54

    Pivot Points

    R3$0.55
    R2$0.53
    R1$0.52
    Pivot Point$0.50
    S1$0.48
    S2$0.46
    S3$0.45

    Advanced Oscillators

    TSI-17.62
    Ultimate Osc36.7
    KST-137.34

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$5.55M$5.64M$5.02M$4.72M$4.61M$4.75M$5.11M$4.56M$5.17M$4.38M$5.38M$5.71M
    Cost of Revenue$2.52M$2.38M$2.02M$1.94M$1.78M$1.79M$1.71M$2.10M$1.77M$1.80M$1.82M$2.16M
    Gross Profit$3.04M$3.26M$3.00M$2.78M$2.83M$2.96M$3.40M$2.45M$3.40M$2.58M$3.56M$3.55M
    Operating Expenses$4.17M$4.06M$3.29M$3.46M$3.74M$3.45M$3.49M$2.78M$3.79M$4.13M$4.62M$18.58M
    R&D$0$0$808$0$0$0$0$0$0$0$0$0
    SG&A$0$0$1.69M$0$0$0$0$0$0$0$0$0
    Operating Income$-1,130,477$-800,784$-286,288$-685,816$-904,686$-485,816$-86,272$-316,556$-382,028$-1,550,991$-1,065,835$-15,217,072
    Interest Income$0$0$3,157$0$0$0$0$0$0$0$0$0
    Interest Expense$-3,275$-2,806$0$-5,848$-9,414$-7,642$-11,404$-2,051$12,741$18,399$418$-37,775
    Income Before Tax$-1,127,202$-797,978$-283,131$-679,968$-895,272$-480,757$15,095$-152,800$459,737$-3,010,562$-996,501$-15,874,941
    Income Tax Expense$0$0$41.47M$0$0$0$0$0$0$0$0$0
    Net Income$-1,127,202$-797,978$-283,131$-679,968$-895,272$-480,757$15,095$-152,800$459,737$-3,010,562$-996,501$-15,874,941
    EBITDA$-689,359$-800,784$133,499$-253,279$-456,173$87,335$130,342$-74,018$1.06M$-2,412,283$-421,918$-15,143,508
    EBIT$-1,130,477$-800,784$-283,131$-685,816$-904,686$-488,399$-286,288$-150,023$472,478$-2,996,991$-996,083$-16,098,355
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about YCBD

    News

    Maxim Group Downgrades CbdMD(YCBD.US) to Hold Rating, Cuts Target Price to $0.5

    Maxim Group has downgraded CbdMD (YCBD.US) from a "Buy" to a "Hold" rating and significantly reduced its target price from $5.00 to $0.50. This decision reflects a more cautious outlook on the company's financial prospects and market position.

    Moomoo•8/20/26•
    Bearish

    YCBD Downgraded by Maxim Group -- Rating Changed to Hold

    cbdMD Inc (YCBD) has been downgraded to a Hold rating by Maxim Group due to concerns about its valuation and profitability. The stock is considered significantly overvalued, trading at 230.5% above its GF Value of $0.15, and has a low GF Score of 39/100, reflecting below-average performance across key financial metrics. Investors are advised to exercise caution given the analyst downgrade, high overvaluation, and lack of positive insider or guru activity.

    GuruFocus•8/17/26•
    Bearish

    Maxim Group Downgrades cbdMD to Hold From Buy

    Maxim Group has downgraded cbdMD (YCBD) to a "Hold" rating from its previous "Buy" recommendation. The article provides recent news headlines related to cbdMD, including its Q3 2026 earnings call and results, as well as product distribution and executive appointments. cbdMD is a consumer wellness company focusing on hemp-derived cannabinoid products and other natural compounds.

    marketscreener.com•8/17/26•
    Bearish

    cbdMD Q3 2026 Earnings Call: Complete Transcript

    cbdMD (AMEX: YCBD) reported a 20% year-over-year increase in net sales to $5.6 million for Q3 2026, driven by a 61% growth in the wholesale channel, with contributions from the Bluebird Botanicals acquisition. Despite increased operating loss due to strategic investments and one-time costs, adjusted EBITDA loss narrowed. The company is actively pursuing cost-reduction programs, expects significant monthly savings, and is navigating a dynamic regulatory landscape with new product launches like the zero-proof kava beverage, while also evaluating M&A opportunities for diversification and shareholder value.

    Benzinga•8/13/26•
    Somewhat-Bullish

    Earnings call transcript: cbdMD misses Q3 2026 EPS as shares fall after hours

    cbdMD Inc. (YCBD) reported a mixed fiscal third quarter for 2026, with revenue beating estimates but a wider-than-expected loss per share. The company posted an adjusted loss of 11 cents per share on $5.55 million in revenue, leading to a 9.4% decline in shares after hours. Management announced a new cost-cutting program aiming for $100,000-$150,000 in monthly savings and is focusing on diversifying product lines and distribution channels amidst a dynamic regulatory environment.

    Investing.com•8/13/26•
    Somewhat-Bearish

    Frequently Asked Questions About YCBD

    Does YCBD pay dividends?
    cbdMD Inc (YCBD) does not currently pay a regular dividend.
    What is YCBD's market cap?
    cbdMD Inc (YCBD) has a market capitalization of $5.60M with a current stock price of $0.49.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In